Lymphoma Cancer Treatments – Extreme Drug Resistance
Learn More About Lymphoma Extreme Drug Resistance: Chat with Us | Email Us
Extreme Drug Resistance for Lymphoma
At Cancer Treatment Centers of America (CTCA), we tailor your lymphoma cancer treatment plan to your specific needs. One of the innovative ways CTCA cancer experts customize your lymphoma cancer treatment is by using the Extreme Drug Resistance (EDR) Assay (also known as chemoresistance). The EDR Assay helps test how you are likely to respond to specific chemotherapeutic drugs.
A highly accurate test for solid tumors, the EDR assay is used to determine the probability of a tumor’s resistance to a specific chemotherapy drug. If tumor cells continue to grow while in the presence of extreme exposure to a certain chemotherapy drug, it indicates significant drug resistance. Thus, if a tumor is resistant to a drug in an EDR assay, then the actual tumor in the body will most likely be resistant to that drug.
By testing for drug resistance prior to initiating therapy, the Extreme Drug Resistance Assay can help CTCA cancer doctors avoid unnecessary toxicity to you, minimize costs, and consider other lymphoma cancer treatment protocols.
Next Topic: MRI for Lymphoma